Telatinib mesylate - ≥99% , CAS No.332013-26-0

CAS: 332013-26-0 Cat. No.: T648659 Formula: C21H20ClN5O6S Peso molecolare: 505.93
Disponibile su ordine
QUALITÀ & PUREZZA ≥99%
Storage
Store at 2-8°C,Desiccated
Shipped In
Wet ice
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
5mg
T648659-5mg
Su ordinazione · 8–12 settimane

22,47€

33,76€
Salva 11,28 € (33.42%)
10mg
T648659-10mg
Su ordinazione · 8–12 settimane

40,70€

61,52€
Salva 20,83 € (33.85%)
25mg
T648659-25mg
Su ordinazione · 8–12 settimane

88,42€

132,68€
Salva 44,25 € (33.36%)
50mg
T648659-50mg
Su ordinazione · 8–12 settimane

149,16€

223,79€
Salva 74,63 € (33.35%)
100mg
T648659-100mg
Su ordinazione · 8–12 settimane

254,16€

381,72€
Salva 127,56 € (33.42%)
Enter a quantity for the sizes you want to add.

Panoramica

Telatinib mesylate (Bay 57-9352 mesylate) is a potent and orally active VEGFR2 , VEGFR3 , PDGFα , and c-Kit inhibitor with IC 50 s of 6 nM, 4 nM, 15 nM and 1 nM, respectively

In Vitro

Telatinib enhances the anticancer activity of ABCG2 substrate anticancer drugs by inhibiting ATP-binding cassette G2 (ABCG2) efflux transporter activity. Co-incubation of ABCG2-overexpressing drug resistant cell lines with Telatinib and ABCG2 substrate anticancer drugs significantly reduces cellular viability, whereas Telatinib alone does not significantly affect drug sensitive and drug resistant cell lines. Telatinib at 1 μM does not significantly alter the expression of ABCG2 in ABCG2-overexpressing cell lines. Telatinib at 1 μM significantly enhances the intracellular accumulation of [ 3 H]-mitoxantrone (MX) in ABCG2-overexpressing cell lines. Telatinib at 1 μM significantly reduces the rate of [ 3 H]-MX efflux from ABCG2-overexpressing cells. Furthermore, Telatinib significantly inhibits ABCG2-mediated transport of [ 3 H]-E₂17βG in ABCG2 overexpressing membrane vesicles. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Telatinib (15 mg/kg; oral dministration; every 2nd and 3rd day; total 12 times; male athymic NCR (nu/nu) nude mice) with Doxorubicin (1.8 mg/kg) significantly decreases the growth rate and tumor size of ABCG2 overexpressing tumors in a xenograft nude mouse model. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male athymic NCR (nu/nu) nude mice (13-15 g, age 4-5 weeks) injected with H460 and H460/MX20 cellsDosage: 15 mg/kg Administration: Oral dministration; every 2nd and 3rd day; total 12 times Result: With Doxorubicin (1.8 mg/kg) significantly decreased the growth rate and tumor size of ABCG2 overexpressing tumors in a xenograft nude mouse model.

Form:Solid

IC50& Target:VEGFR2 6 nM (IC 50 ) VEGFR3 4 nM (IC 50 ) PDGFRα 15 nM (IC 50 ) c-Kit 1 nM (IC 50 )

Specifiche

Specifiche e purezza
≥99%
Meccanismi biochimici e fisiologici
Telatinib mesylate (Bay 57-9352 mesylate) is a potent and orally active VEGFR2 , VEGFR3 , PDGFα , and c-Kit inhibitor with IC 50 s of 6 nM, 4 nM, 15 nM and 1 nM, respectively.
Condizioni di conservazione di stoccaggio
Store at 2-8°C,Desiccated
Spedito in
Wet ice
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Purezza
≥99%
Nomi e identificatori
SMILES
O=C(C1=NC=CC(COC2=NN=C(NC3=CC=C(Cl)C=C3)C4=C2OC=C4)=C1)NC.OS(=O)(C)=O
Peso molecolare
505.93

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Proprietà chimiche e fisiche
SolubilitàDMSO : 250 mg/mL (494.14 mM; Need ultrasonic)
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.